echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Zhejiang drug bidding is about to start, and the supplementary catalogue of basic drugs is expected to be released this month

    Zhejiang drug bidding is about to start, and the supplementary catalogue of basic drugs is expected to be released this month

    • Last Update: 2014-08-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: asidak news agency, 2014-08-13 big smart news agency, learned exclusively that after four months of work stagnation, the preparation for drug bidding in Zhejiang Province started again The person in charge of the bidding Office of Zhejiang Province delivered the wind direction of this round of bidding to drug manufacturers at the symposium recently organized, We will "subversively" break the bidding rules of "no quality stratification" in the past, consider quality stratification and group bidding, and "support the low and suppress the high" become the key words of this round of bidding A participant told the big wisdom news agency that the new round of drug bidding and purchase in Zhejiang started the bidding for basic drugs first, and then the bidding for non basic drugs According to the management idea of classified procurement of national health and Family Planning Commission, basic drug bidding is divided into six categories: national basic drug catalog, provincial supplement catalog, basic low drug catalog, supply shortage catalog, non mainstream product catalog and big infusion catalog Among them, the provincial supplementary catalogue, which has been brewing for nearly a year, is expected to be published in August, when more than 100 varieties will be added From the perspective of the overall bidding wind direction, "supporting the low and restraining the high" has become the key words of bidding There is no price reduction for low-cost drugs and the original national basic drug catalog varieties, but there is a 10% price reduction threshold for other bidding varieties For the top 200 varieties with the largest sales volume, the price will be reduced by 2% - 5% based on the 10% price reduction It can be seen that Zhejiang's strict attitude towards the protection of low-cost drugs and the price of high-cost drugs, if some varieties with large sales volume choose to enter the market, they will face up to 15% price cutting At the same time, this round of bidding in Zhejiang will also strictly control the price of high-quality level in the bidding process Although the province breaks the traditional bidding method of base drug without quality level, and divides three quality levels into group bidding, so that high-quality varieties such as patents, original research and so on can avoid positive price competition However, in the bid winning results, the first and second levels can only win the bid at the lowest price, which is limited to hospitals above the county level The third level can win three bid winning numbers with the highest, second and lowest comprehensive scores according to the number of shortlisted economic and technical bids, which can be used by the grass-roots level and above the county level.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.